One can feel the CTIX suspense growing, especially with this coil/triangle awaiting to spring upward.
A sampling of lines from Leo's most recent PR at http://cellceutix.com/cellceutix-ceo-discusse...-for-2013/ :
--"I could not be more pleased with the progression of our Company or more excited about 2013."
--"The information that we have received at this early stage of the trial so far has been very encouraging..."
--"We expect some information on pharmacokinetics from the early cohorts in the near term."
--"We will be releasing details about the University very shortly."
--"The University has indicated they are interested in a second study of Kevetrin in combination with a compound of a major European pharmaceutical company."
--"...the Company has recently been approached by one of the world’s most prominent cancer centers (the “Cancer Center”), located in the Southwest United States."
--"Manufacturing of cGMP Prurisol is expected to begin in about a months time."
--"(regarding Prurisol)...we have high expectations for these trials to support a larger scale, late stage clinical trial. I believe updates on these trials will be quite frequent."
--"Kevetrin is an extremely unique drug, actually classified as a new class of chemistry in medicine, and its ability to re-activate p53 could simply be unprecedented if it continues to show low toxicity. There is no comparison of Kevetrin to any other compound."
--"...psoriasis represents a multi-billion dollar opportunity and an area of great unmet medical need."
--"I have stated in the past, “the best is yet to come”..."